loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people..
�we have waited a long time and we cannot possibly wait any longer,� karmenu vella, european commissioner for environment, told the guardian...: bwire: the major problem at knh is structural and system failures.
"we are calling for the immediate implementation of a statutory duty of candour for the health trusts.".